New applications for sublingual immunotherapy in allergy

Recent Patents on Inflammation and Allergy Drug Discovery

Volumn 3, Issue 2, 2009, Pages 113-117

  Incorvaia, Cristoforo ^a,d   Mauro, Marina ^b   Cappelletti, Tiziana ^a   Pravettoni, Chiara ^a   Leo, Gualtiero ^c   Riario Sforza, Gian G ^a  

^a ICP Hospital   (Italy)

^b SANT ANNA HOSPITAL   (Italy)

^c V BUZZI CHILDREN S HOSPITAL   (Italy)

^d NONE   (Italy)

Author keywords

Atopic dermatitis; Baker's asthma; Efficacy; Food allergy; Hymenoptera venom allergy; Latex allergy; Safety; Sublingual immunotherapy

Indexed keywords

HYMENOPTERA VENOM; IMMUNOMODULATING AGENT; INTERLEUKIN 6; INTERLEUKIN 8; LATEX; ALLERGEN;

ALLERGIC ASTHMA; ALLERGY; ANAPHYLAXIS; ARTICLE; ATOPIC DERMATITIS; CYTOKINE RELEASE; DESENSITIZATION; DRUG EFFICACY; DRUG SAFETY; FOOD ALLERGY; HUMAN; IMMUNOTHERAPY; PRIORITY JOURNAL; HYPERSENSITIVITY; IMMUNOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION; SUBLINGUAL DRUG ADMINISTRATION;

ADMINISTRATION, SUBLINGUAL; ALLERGENS; DESENSITIZATION, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY; INJECTIONS, SUBCUTANEOUS;

EID: 68949190873     PISSN: 1872213X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221309788489742     Document Type: Article

References (55)

1. Committee on the Safety of Medicines. CSM update. Desensitizing vaccines. Br Med J 1986; 293: 948.
2. Lockey RF, Benedict LM, Turkeltaub PC, Bukantz SC. Fatalities from immunotherapy and skin testing. J Allergy Clin Immunol 1987; 79: 660-677.
3. Canonica GW, Passalacqua G. Noninjection routes for immunetherapy. J Allergy Clin Immunol 2003; 111: 437-448.
4. Wilson DR, Torres Lima M, Durham SR. Sublingual immunotherapy for allergic rhinitis: Systematic review and meta-analysis. Allergy 2005; 60: 4-12.
5. Gidaro GB, Marcucci F, Sensi L, Incorvaia C, Frati F, Ciprandi G. The safety of sublingual-swallow immunotherapy: An analysis of published studies. Clin Exp Allergy 2005; 35: 565-571.
6. Calamita Z, Saconato H, Pel AB, Atallah N. Efficacy of sublingual immunotherapy in asthma: Systematic review of randomized-clinical trials using the Cochrane Collaboration Method. Allergy 2006; 61: 1162-1172.
7. Penagos M, Passalacqua G, Compalati E, et al. Meta-analysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age. Chest 2008; 133: 599-609.
8. Chapman JA, Bernstein L, Lee RE, et al. Food allergy: A practice parameter. Ann Allergy Asthma Immunol 2006; 96: 1-29.
9. Nelson HS, Lahr J, Rule R, Bock A, Leung D. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol 1997; 99: 744-751.
10. Koppelman, S.J.: US2007190069 (2007).
11. Barbi E, Berti I, Longo G. Food allergy: from the loss of tolerance induced by exclusion diets to specific oral tolerance induction. Recent Pat Inflamm Allergy Drug Discov 2008; 2: 212-214.
12. Scurlock AM, Steele PH, Andrzejewski SS, et al. Safety of oral peanut immunotherapy for peanut allergy patients. J Allergy Clin Immunol 2005; 115: S246.
13. Patriarca G, Nucera E, Pollastrini E, et al. Oral rush desensitization in peanut allergy: A case report. Dig Dis Sci 2006; 51: 471-473.
14. Mansfield L. Successful oral desensitization for systemic peanut allergy. Ann Allergy Asthma Immunol 2006; 97: 266-267.
15. Meglio P, Bartone E, Plantamura M, Arabito E, Giampietro PG. A protocol for oral desensitization in children with IgE-mediated cow's milk allergy. Allergy 2004; 59: 980-987.
16. de Boissieu D, Dupont C. Sublingual immunotherapy for cow's milk protein allergy: A preliminary report. Allergy 2006: 61: 1238-1239.
17. Longo G, Barbi E, Berti I, et al. Specific oral tolerance induction in children with very severe cow's milk-induced reactions. J Allergy Clin Immunol 2008; 121: 343-347.
18. Buchanan AD, Green TD, Jones SM, et al. Egg oral immunotherapy in nonanaphylactic children with egg allergy. J Allergy Clin Immunol 2007; 119: 199-205.
19. Enrique E, Pineda F, Malek T, et al. Sublingual immunotherapy for hazelnut food allergy: A randomized, double-blind, placebocontrolled study with a standardized hazelnut extract. J Allergy Clin Immunol 2005; 116: 1073-1079.
20. Enrique E, Malek T, Pineda F, et al. Sublingual immunotherapy for hazelnut food allergy: A follow-up study. Ann Allergy Asthma Immunol 2008; 100: 283-284.
21. Leynadier F, Herman D, Vervloet D, André C. Specific immunotherapy with a standardized latex extract versus placebo in allergic healthcare workers. J Allergy Clin Immunol 2000; 106: 585-590.
22. Sastre J, Fernandez-Nieto M, Rico P, et al. Specific immunotherapy with standardized latex extract in allergic workers: A double-blind, placebo-controlled study. J Allergy Clin Immunol 2003; 111: 985-994.
23. Tabar AI, Anda M, Bonifazi F, et al. Specific immunotherapy with standardized latex extract versus placebo in latex-allergic patients. Int Arch Allergy Immunol 2006; 141: 369-376.
24. Bernardini R, Campodonico P, Burastero S, et al. Sublingual immunotherapy with a latex extract in paediatric patients: A double-blind, placebo-controlled study. Curr Med Res Opin 2006; 22: 1515-1522.
25. Bernardini R, Pecora S, Milani M, et al. Natural rubber latex allergy in children: Clinical and immunological effects of 3-years sublingual immunotherapy. Eur Ann Allergy Clin Immunol 2008; 40: 142-47.
26. Antico A, Pagani M, Crema A. Anaphylaxis by latex sublingual immunotherapy. Allergy 2006; 61: 1236-1237.
27. Nucera E, Schiavino D, Sabato V, et al. Sublingual immunotherapy for latex allergy: Tolerability and safety profile of rush buildup phase. Curr Med Res Opin 2008; 24: 1147-54.
28. Holm, J., Ferreras, M.: US2004043438 (2004).
29. Rolland JM, Drew AC, O'Hehir RE. Advances in development of hypoallergenic latex immunotherapy. Curr Opin Allergy Clin Immunol 2005; 5: 544-551.
30. Incorvaia C, Frati F, Verna N, et al. Allergy and the skin. Clin Exp Immunol 2008; 153 (Suppl 1): 27-29.
31. Peterson JD, Chan LS. A comprehensive management guide for atopic dermatitis. Dermatol Nurs 2006; 18: 531-542.
32. Caplan, M., Bannon, G.A., Burks, W., Sampson, H.: US20010031262 (2001).
33. Kawamoto, M., Tanaka, K., Amiya, S., Aruga, M.: US2008279905 (2008).
34. Brown A, Farmer K, MacDonald L, et al. House dust mite Der p1 downregulates defenses of the lung by inactivating elastase inhibitors. Am J Resp Cell Mol Biol 2003; 29: 381-389.
35. Cork MJ, Robinson DA, Vasilopoulos Y, et al. New perspectives on epidermal barrier dysfunction in atopic dermatitis: Geneenvironment interactions. J Allergy Clin Immunol 2006; 118: 13-21.
36. Fuiano N, Incorvaia C, Prodam F, Procaccini DA, Bona G. Relationship between the atopy patch test and clinical expression of the disease in children with atopic eczema/dermatitis syndrome and respiratory symptoms. Ann Allergy Asthma Immunol 2008; 101: 174-178.
37. Bussmann C, Bockenhoff A, Henke H, Werfel T, Novak N. Does allergen specific immunotherapy represent a therapeutic option for patients with atopic dermatitis? J Allergy Clin Immunol 2006; 118; 1292-1298.
38. Bussmann C, Maintz L, Hart J, et al. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: A pilot study. Clin Exp Allergy 2007; 37: 1277-1285.
39. Pajno GB, Caminiti L, Vita D, et al. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: A randomized, double-blind, placebo-controlled study. J Allergy Clin Immunol 2007; 120: 164-170.
40. Cadario G, Galluccio AG, Pezza M, et al. Sublingual immunotherapy efficacy in patients with atopic dermatitis and house dust mites sensitivity: A prospective pilot study. Curr Med Res Opin 2007; 23: 2503-2506.
41. Battais F, Richard C, Jacquenet S, Denery-Papini S, Moneret-Vautrin DA. Wheat grain allergies: An update on wheat allergens. Eur Ann Allergy Clin Immunol 2008; 40: 67-76.
42. Brant A. Baker's asthma. Curr Opin Allergy Clin Immunol 2007; 7: 152-155.
43. Pastorello EA, Farioli L, Conti A, et al. Wheat IgE-mediated food allergy in European patients: Alpha-amylase inhibitors, lipid transfer proteins and low-molecular-weight glutenins. Allergenic molecules recognized by double-blind, placebo-controlled food challenge. Int Arch Allergy Immunol 2007; 144: 10-22.
44. Weichel M, Vergoossen NJ, Bonomi S, et al. Screening the allergenic repertoires of wheat and maize with sera from doubleblind, placebo-controlled food challenge positive patients. Allergy 2006; 61: 128-135.
45. Incorvaia C, Riario-Sforza GG, Mauro M, Frati F. A case for treatment with sublingual immunotherapy in asthma and food allergy to cereals. Allergy 2007; 62 (Suppl 83): 263-264.
46. Muller U, Golden DBK, Lockey RF, Shin B. Immunotherapy for Hymenoptera venom hypersensitivity. Clin Allergy Immunol 2008; 21: 377-392.
47. Hunt KJ, Valentine MD, Sobotka AK, et al. A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med 1978; 299: 157-161.
48. Kelly D, Golden DBK, Hamilton RG, Craig TJ. Venom immunotherapy reduces large local reactions to insect stings. J Allergy Clin Immunol 2007; 119: S79.
49. Severino MG, Cortellini G, Bonadonna P, et al. Sublingual immunotherapy for large local reactions caused by honeybee stings: A double-blind, placebo-controlled trial. J Allergy Clin Immunol 2008; 122: 44-48.
50. Bousquet J, van Cauwenberge P, Eds. Allergic Rhinitis and its Impact on Asthma (ARIA). J Allergy Clin Immunol 2001; 108(Suppl 5): 147-334.
51. Carnes J, Robinson DS. New strategies for allergen immunotherapy. Recent Pat Inflamm Allergy Drug Discov 2008; 2: 92-101.
52. Pajno GB. Sublingual immunotherapy: The optimism and the issues. J Allergy Clin Immunol 2007; 119: 796-801.
53. Frew AJ. Sublingual immunotherapy. N Eng J Med 2008; 358: 2259-2264.
54. Incorvaia C, Frati F, Sensi L, Riario-Sforza GG, Marcucci F. Allergic inflammation and the oral mucosa. Recent Pat Inflamm Allergy Drug Discov 2007; 1: 35-38.
55. Burks AW, Laubach S, Jones SM. Oral tolerance, food allergy, and immunotherapy: Implications for future treatment. J Allergy Clin Immunol 2008; 121: 1344-1350.